Document Detail


Gestational thrombocytopenia and immune thrombocytopenias in pregnancy.
MedLine Citation:
PMID:  11005036     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Appropriate management of thrombocytopenia in the pregnant patient is important for the well-being of both mother and fetus. The healthy-appearing mother with mild thrombocytopenia may have either gestational benign thrombocytopenia, which does not produce fetal thrombocytopenia, or immune-mediated thrombocytopenia, which can produce fetal thrombocytopenia. These two types of pregnancy-associated thrombocytopenias can be differentiated. Gestational benign thrombocytopenia is initially discovered during pregnancy, and in these patients a reliable test for antiplatelet antibody is usually negative. Conversely, patients with immune-mediated thrombocytopenia may have a history of thrombocytopenia before the pregnancy, and these patients usually have a detectable antiplatelet antibody. The pregnancy patient who presents with a normal platelet count and a history of neonatal alloimmune thrombocytopenia in a prior pregnancy or with a history of an infant of a close relative with NAT must be carefully monitored. Antiplatelet antibody assays performed on mother's and baby's blood will help determine if an antiplatelet antibody is present in maternal plasma, if the antibody reacts with the baby's platelets, and (with appropriate typing plasma) the antigenic specificity of the maternal and fetal platelets. In addition, antigenic typing of the father's platelets will help determine the risk of NAT in the current pregnancy. If a fetus is at risk for severe immune-mediated thrombocytopenia from either an autoantibody or an alloantibody, the fetal platelet count should be measured, if possible, from blood obtained by umbilical cord puncture. If the fetal platelet count is less than 50,000/microL or cannot be measured but is thought to have a high probability of being less than 50,000/microL, strong consideration should be given to a cesarean delivery.
Authors:
K A Schwartz
Related Documents :
14609046 - A pilot study on cd4 & cd8 cell counts in healthy hiv seronegative pregnant women.
15176736 - Uterine mast cells: a new hypothesis to understand how we are born.
6285746 - Lymphocyte cyclic amp levels antepartum and postpartum as an indirect assessment of the...
21482376 - Comparison of the effect of two different doses of recombinant gonadotropin for ovarian...
18951216 - History of cesarean before 32 weeks' gestation and trial of labor: what is the risk of ...
11169356 - The prenatal diagnosis of binder syndrome before 24 weeks of gestation: case report.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Hematology/oncology clinics of North America     Volume:  14     ISSN:  0889-8588     ISO Abbreviation:  Hematol. Oncol. Clin. North Am.     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-12-27     Completed Date:  2001-01-04     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8709473     Medline TA:  Hematol Oncol Clin North Am     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1101-16     Citation Subset:  IM    
Affiliation:
Department of Medicine, Michigan State University, East Lansing, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies / blood
Autoimmune Diseases*
Blood Platelets / immunology
Female
Fetal Blood / cytology
Fetal Diseases / immunology
Humans
Infant, Newborn
Isoantibodies / blood
Platelet Count
Pregnancy
Pregnancy Complications, Hematologic*
Thrombocytopenia / diagnosis*,  immunology*,  therapy
Chemical
Reg. No./Substance:
0/Antibodies; 0/Isoantibodies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical and laboratory features and sequelae of deficiency of folic acid (folate) and vitamin B12 (...
Next Document:  Recurrent miscarriage syndrome and infertility caused by blood coagulation protein or platelet defec...